禮來公司(Eli Lilly)在Novo肥胖交易後放棄了針對工人的CVS藥物計劃

在Novo obesity交易後，禮來公司(Eli Lilly)決定放棄其員工的CVS藥物計劃。這一決定是在禮來公司和Novo最近達成一項與肥胖相關的協議之後做出的。此舉對於禮來公司的員工來說意義重大，他們將不再獲得CVS藥物計劃。彭博新聞報道了這一決定。

相關股票

相關資訊

小米發佈2025年雙11戰報，全渠道累計支付金額破290億元

老虎资讯综合·2025/11/12

小米發佈2025年雙11戰報，全渠道累計支付金額破290億元

港股異動 | 小米集團-W(01810)漲超3% 雙十一全渠道累計支付金額破290億元

智通财经·2025/11/12

港股異動 | 小米集團-W(01810)漲超3% 雙十一全渠道累計支付金額破290億元

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/economy/c9490a766ae9c27b2daef2d1f34b1825"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://community-service.laohu8.com/v1/financial/theme/news\",params:#themeId:\"c9490a766ae9c27b2daef2d1f34b1825\",region:\"SGP\",,,undefined,":{"bottom":false,"list":[{"cardType":"NEWS","cardId":"NEWS.1170317422","cardData":[{"id":"1170317422","pubTimestamp":1762913981,"title":"小米發佈2025年雙11戰報，全渠道累計支付金額破290億元","summary":"","media":"老虎资讯综合","labels":[],"importantFlag":0,"likeCount":0,"liked":false,"publishNews":true,"publishLive":true}],"position":0},{"cardType":"NEWS","cardId":"NEWS.2582176603","cardData":[{"id":"2582176603","pubTimestamp":1762913681,"title":"港股異動 | 小米集團-W(01810)漲超3% 雙十一全渠道累計支付金額破290億元","summary":"","media":"智通财经","labels":["dataReport"],"importantFlag":0,"likeCount":0,"liked":false,"publishNews":true,"publishLive":false,"news_tag":"dataReport"}],"position":0}],"size":2,"extra":{"requestId":"7221680da968478a8cb9a0637d64bc30"}},"@#url:\"https://community-service.laohu8.com/v1/theme/info\",params:#region:\"SGP\",,method:\"POST\",data:#themeId:\"c9490a766ae9c27b2daef2d1f34b1825\",,,undefined,":{"themeId":"c9490a766ae9c27b2daef2d1f34b1825","name":"禮來公司(Eli Lilly)在Novo肥胖交易後放棄了針對工人的CVS藥物計劃","description":"在Novo obesity交易後，禮來公司(Eli Lilly)決定放棄其員工的CVS藥物計劃。這一決定是在禮來公司和Novo最近達成一項與肥胖相關的協議之後做出的。此舉對於禮來公司的員工來說意義重大，他們將不再獲得CVS藥物計劃。彭博新聞報道了這一決定。","image":"https://static.tigerbbs.com/c9496255132e43956aaf36fe6dddbc07","type":2,"style":4,"follow":false,"createTime":1762915571428,"userCounts":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/special/finance&rndata={\"themeId\":c9490a766ae9c27b2daef2d1f34b1825}&rnconfig={\"headerBarHidden\": true}","subscribe":false,"allowFollow":false,"hasReward":false,"rewardScore":0,"rewardValidDate":0,"rewardEnd":false,"symbols":["CVS","LLY"],"tweetCounts":0,"categoryId":"2929bb7468f5415f853fd96fb35d7c3b","options":[],"votedOptionId":"","totalUserCount":0,"followStatus":false,"themeName":"禮來公司(Eli Lilly)在Novo肥胖交易後放棄了針對工人的CVS藥物計劃","tweetAmount":0,"imageIsDefault":false,"aiDerivativeIssues":[]}}}